Intra-city differences in psychotropic drug use: A Nigerian scene

The Journal of the Royal Society for the Promotion of Health

Volumn 116, Issue 5, 1996, Pages 299-303

  Famuyiwa, O O ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; CHLORPROMAZINE; HALOPERIDOL; PSYCHOTROPIC AGENT; TRANQUILIZER; TRIFLUOPERAZINE;

ARTICLE; DRUG USE; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE DELIVERY; MENTAL DISEASE; MENTAL HEALTH SERVICE; NIGERIA; PHYSICIAN; PRESCRIPTION; RESPONSIBILITY; WORKLOAD;

ADOLESCENT; ADULT; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NIGERIA; PATIENT CARE TEAM; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; URBAN POPULATION;

EID: 0029819612     PISSN: 14664240     EISSN: None     Source Type: Journal    
DOI: 10.1177/146642409611600507     Document Type: Article

References (24)

1. Baldessarini R.J. (1989). Current status of antidepressants. Clinical Pharmacology and Therapy. J of Clinical Psychiatry; 50, 117-126
2. Blackwell B. (1973). Psychotropic drugs in use today. The role of diazepam in medical practice. JAMA; 225, 1637-1641
3. Bolin P.R. (1960). Psychiatric manifestations of artane toxicity. J of Nerv Ment Diseases; 13, 256-259
4. Cluff L.E. and Petrie J.C. (1974). Clinical effects of interactions between drugs. New York: American Elseyler
5. Cole J.O. (1964). Therapeutic efficacy of anti-depressant drugs. JAMA; 190, 448-455
6. Dimascio A. and Shader R.I. (1969). Drug administration schedules. Am J of Psychiatry; 126, 796-801
7. Gelenberg A.J., Van Putten T., Lavori P.W. et al (1989). Anticholinergic effects on memory: Benzotropine versus anantadine. J Clin Psychopharmacology; 9, 180-185
8. Greenblatt M., Grosser G.H. and Wechsler H.A. (1962). A comparative study of selected anti-depressant medications. Am J Psychiatry; 119, 144-153
9. Grahaeme-Smith D. G (1977). Drug Interactions. Baltimore : University Part Press Hanlon T.E., Ota K.Y., Agallianos D.D., Berman S.A., Bethan G.D., Kobler F. and Kurland A.A. (1969). Combined
10. drug treatment of newly hospitalised acutely ill psychiatric patients. Dis of Nervous System; 30 (10), 104-116
11. Hansten P.D. (1975). Drug Interactions. Philadelphia : Lea and Febiger
12. Klett C.J. and Caffey E. (1972). Evaluating the long-term need for anti-parkinsonian agents by chronic schizophrenics. Archives of Gen Psychiatry; 26, 374-379
13. Manselli P.L., Garattini S. and Cohen S.N. (1974). Drug Interactions. New York : Raven Press
14. McClelland H.A., Blessed G., Bhate S., Alin and Clarke B.A. (1974). The abrupt withdrawal of anti-parkinsonian drugs in schizophrenia. Br J of Psychiatry; 124, 151-159
15. Medical Research Council, Clinical Psychiatry Committee (1965). Clinical trial of the treatment of depressive illness. BMJ; 881-886
16. Muller C. (1976). The over-medicated society : Forces in the market place for medical care. Science; 488-492
17. Obembe A., Abengowe A. and Ahmed M.K. (1989). Clinical effects of tricyclic antidepressants. A study of 60 Nigerians with depressive illness. Nigerian Medical Practitioner; 18 (5 / 6), 30-35
18. Odejide A.O. and Ayinde O. (1978). Psychotropic and anti-parkinsonian drug use: An examination of prescribing practices. African Journal of Psychiatry; 4 (2), 31-36
19. Overo K.F., Gram L. and Hansen V. (1977). Interactions of perphenzine with the kinetics of nortriptyline. Acta Pharmacology Toxicology; 40, 87-105
20. Post R.M. (1990). Treatment of refractory mood disorders. In: Review of Psychiatry, Vol 9, 7-202. Washington DC: American Psychiatric Press
21. Rifkin D. (1978). Are prophylactic anti-parkinsonian drugs necessary? Archives of Gen Psychiatry; 35, 483-489
22. Thornton W.E. and Pray J.J. (1975). Combination Drug Therapy in Psychopharmacology. J of Clinical Pharmacology; 15, 511-517
23. West E.D. (1981). ECT in depression: a double-blind controlled trial. BMJ; 282, 355-357
24. Wood G.E. and O'Brien P.C. (1974). Anticholinergic toxic psychosis in drug abusers treated with bentropine. Compr Psychiatry; 15, 422-439